Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alba Corell

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Acta Neurochirurgica|January 25, 2019
Neurosurgical treatment and outcome patterns of meningioma in Sweden: a nationwide registry-based studyAlba Corell, Erik Thurin, Thomas Skoglund, et al.
Journal of Neuro-Oncology|November 26, 2022
Changes in clinical management of diffuse IDH-mutated lower-grade gliomas: patterns of care in a 15-year periodCaroline Svenjeby, Louise Carstam, Katja Werlenius, et al.
BMC Surgery|September 19, 2024
Observations from the first 100 cases of intraoperative MRI - experiences, trends and short-term outcomesHanna Barchéus, Christoffer Peischl, Isabella M Björkman-Burtscher, et al.
Neurosurgery|January 26, 2026
Sequencing of Cranioplasty and Shunt Surgery After Decompressive Craniectomy: A Swedish Multicenter StudyKlas Holmgren, Alexander Fletcher-Sandersjöö, Bjartur Sæmundsson, et al.
Magma (New York, N.Y.)|June 13, 2026
Effects of echo time and modeling of compartmental T2 on VERDICT parameter estimation in brain tumorsLukas Lundholm, Oscar Jalnefjord, Mikael Montelius, et al.
BMC Cancer|May 22, 2020
The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based studyAlba Corell, Sandra Ferreyra Vega, Nickoleta Hoefling, et al.
Acta Neurochirurgica|March 12, 2025
Decompressive craniectomy in aneurysmal subarachnoid hemorrhage: can favorable outcome be achieved?Teodor Svedung Wettervik, Alba Corell, Merete Sunila, et al.
Neurosurgery|June 26, 2024
The T1/T2 Ratio is Associated With Resectability in Patients With Isocitrate Dehydrogenase-Mutant Astrocytomas Central Nervous System World Health Organization Grades 2 and 3Jonathan Weller, Eddie de Dios, Sophie Katzendobler, et al.
Journal of Neuro-Oncology|May 20, 2025
CDKN2A/B status versus morphology in diagnosing WHO grade 4 IDH-mutated astrocytomas: what is the clinical relevance?Anna Lipatnikova, Teresia Kling, Anna Dénes, et al.
Frontiers in Oncology|January 27, 2022
WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade GliomasLouise Carstam, Alba Corell, Anja Smits, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Acta Neurochirurgica|January 25, 2019
Neurosurgical treatment and outcome patterns of meningioma in Sweden: a nationwide registry-based studyAlba Corell, Erik Thurin, Thomas Skoglund, et al.
Journal of Neuro-Oncology|November 26, 2022
Changes in clinical management of diffuse IDH-mutated lower-grade gliomas: patterns of care in a 15-year periodCaroline Svenjeby, Louise Carstam, Katja Werlenius, et al.
BMC Surgery|September 19, 2024
Observations from the first 100 cases of intraoperative MRI - experiences, trends and short-term outcomesHanna Barchéus, Christoffer Peischl, Isabella M Björkman-Burtscher, et al.
Neurosurgery|January 26, 2026
Sequencing of Cranioplasty and Shunt Surgery After Decompressive Craniectomy: A Swedish Multicenter StudyKlas Holmgren, Alexander Fletcher-Sandersjöö, Bjartur Sæmundsson, et al.
Magma (New York, N.Y.)|June 13, 2026
Effects of echo time and modeling of compartmental T2 on VERDICT parameter estimation in brain tumorsLukas Lundholm, Oscar Jalnefjord, Mikael Montelius, et al.
BMC Cancer|May 22, 2020
The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based studyAlba Corell, Sandra Ferreyra Vega, Nickoleta Hoefling, et al.
Acta Neurochirurgica|March 12, 2025
Decompressive craniectomy in aneurysmal subarachnoid hemorrhage: can favorable outcome be achieved?Teodor Svedung Wettervik, Alba Corell, Merete Sunila, et al.
Neurosurgery|June 26, 2024
The T1/T2 Ratio is Associated With Resectability in Patients With Isocitrate Dehydrogenase-Mutant Astrocytomas Central Nervous System World Health Organization Grades 2 and 3Jonathan Weller, Eddie de Dios, Sophie Katzendobler, et al.
Journal of Neuro-Oncology|May 20, 2025
CDKN2A/B status versus morphology in diagnosing WHO grade 4 IDH-mutated astrocytomas: what is the clinical relevance?Anna Lipatnikova, Teresia Kling, Anna Dénes, et al.
Frontiers in Oncology|January 27, 2022
WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade GliomasLouise Carstam, Alba Corell, Anja Smits, et al.
Pageof 6